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Abstract 
Foot-and-mouth disease virus (FMDV) is responsible for one of the most economically 
important infectious diseases of livestock. The virus spreads very easily and continues to 
affect many countries (mainly in Africa and Asia). The risks associated with the introduction 
of FMDV result in major barriers to trade in animals and their products. Seven antigenically 
distinct forms of the virus are known, called serotypes, but serotype C has not been detected 
anywhere for many years and may now be extinct. The serotypes have been further divided 
into topotypes (except for serotype Asia-1 viruses, which comprise a single topotype), 
genotypes, lineages and sub-lineages, which are usually restricted to specific geographical 
regions. However, sometimes, trans-regional spread of some strains occurs. Due to the error-
prone replication of the RNA genome, the virus continuously evolves and new strains 
frequently arise (e.g. with modified antigenicity). Using nucleotide sequencing technologies, 
this rapid evolution of the viral genome can be followed. This allows the tracing of virus 
transmission pathways within an outbreak of disease if (near) full-length genome sequences 
can be generated. Furthermore, the movement of distinct virus lineages, from one country to 
another can be analysed. Some important examples of the spread of new strains of FMD virus 
are described.      
  
3 
Highlights 
 Seven different serotypes of FMDV exist
 The nucleotide sequence encoding the capsid protein VP1 is sufficient to identify the
serotype and the lineage
 Phylogenetically related virus subtypes/strains within each serotype of FMDV are usually
restricted to distinct geographical regions
 The nucleotide sequence of FMDV evolves very rapidly (upto about 1% of the genome
per year)
 (Near) full-length genome sequencing of the virus allows virus transmission pathways to
be established
 New strains of FMDV continue to arise, these can spread rapidly and can be threats to
disease free areas
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1.1 Introduction 
Foot-and-mouth disease (FMD) is an economically important disease of cloven-hoofed 
animals, affecting a variety of different species of domestic and wild livestock, including 
cattle, pigs, sheep, goats and buffalo.  Although Europe and North America are usually free 
of the disease, it is still endemic in large parts of Asia and Africa (Jamal and Belsham, 2013). 
Sporadic cases of the disease occur in some South American countries. Outbreaks due to 
serotype O FMDV were reported in Colombia in June 2017 (OIE, 2017a) although no clinical 
disease had previously been detected anywhere in South America since 2013 when disease 
was reported in Venezuela. The causative agent of the disease, foot-and-mouth disease virus 
(FMDV), has a single stranded, positive sense, RNA genome (ca. 8,400 nucleotides (nt) in 
length) and belongs to the Aphthovirus genus within the family Picornaviridae. Within the 
virus particles, the genome is packaged in a protein shell that is composed of 60 copies of 4 
different proteins, termed VP1, VP2, VP3 and VP4 (Figure 1). These individual virus 
proteins are produced by proteolytic processing of the polyprotein that is encoded by a single, 
large, open reading frame (ORF, ca. 7000 nt) within the viral RNA (Figure 1). The 
polyprotein of FMDV includes two separate proteases (L
pro
 and 3C
pro
). The viral structural 
proteins are derived from the P1-2A capsid precursor (Figure 1). The non-structural proteins 
(NSPs) are mainly involved in the replication of the virus and modifying the host cell 
responses to infection (reviewed in Martinez-Salas and Belsham, 2017). The virus exists in 
seven antigenically distinct forms, called serotypes, i.e. O, A, C, Asia-1, Southern African 
Territories (SAT) 1, 2 and 3. The serotype is determined by the surface exposed capsid 
proteins VP1, VP2 and VP3 (note that the VP4 is located internally within the virus particle, 
see Acharya et al., 1989). There is no cross-protection between these serotypes so animals 
vaccinated or infected with one serotype remain susceptible to infection by the other 
serotypes (Rodriguez and Grubman, 2009).  
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The serotypes O, A and C have had a worldwide distribution, with serotype O being 
responsible for the majority of the outbreaks globally. In contrast, serotype Asia-1 and the 
SAT viruses are normally restricted to Asia and sub-Saharan Africa, respectively 
(Rweyemamu et al., 2008). However, there has been an incursion of serotype Asia-1 viruses 
as far west as Greece in 2000 (Valarcher et al., 2008) and occasional incursions of SAT 1 and 
SAT 2 viruses from Africa into the Middle East (Rweyemamu et al., 2008; see below in 
section 3.1.8). The last outbreaks of FMD due to serotype C viruses were recorded in 2004 in 
Brazil and Kenya (Rweyemamu et al., 2008; Roeder and Knowles, 2009; Sangula et al., 
2011) and this serotype is now apparently extinct. It is, however, worth mentioning that a 
SAT 3 serotype FMDV was identified from Uganda from a sample collected in 2013 after a 
period of more than 15 years without detection in that region. Indeed, the most recently 
reported isolation of SAT 3 FMDV, previous to this, was in South Africa in 2006. The recent 
Ugandan virus is of a different lineage than the South African viruses (Dhikusooka et al., 
2015) and this latest isolate is most closely related to other, earlier, Ugandan strains of SAT 3 
FMDV. The lack of detection of this virus in Uganda in the intervening years probably 
reflects the relatively infrequent sampling of the African buffalo populations in which these 
viruses are maintained.   
Different subtypes exist within each serotype and new subtypes arise over time as the virus 
continually evolves (see below). Sometimes there is a lack of efficient cross-protection 
between different subtypes within a single serotype and thus characterization of subtypes 
becomes necessary for selection of appropriate vaccines to control an outbreak in countries 
where vaccination is employed. Different subtypes within each serotype are usually restricted 
to distinct geographical regions (Rweyemamu et al., 2008; Knowles et al., 2016a).  Thus, 
FMDV subtypes within each serotype throughout the world have been sub-divided into seven 
regional pools (e.g., pool 2 comprises viruses from countries within the Indian sub-continent, 
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except Pakistan, while pool 4 includes FMDVs from countries in North-eastern Africa). 
These pools are based on genetic and antigenic analyses (see Di Nardo et al., 2011; Jamal and 
Belsham, 2013; Sumption et al., 2012). However, occasional spread of subtypes beyond their 
usual regions occurs.   
1.1.1 Error-prone replication of FMDV 
As with other picornaviruses, FMDV RNA replicates within the cytoplasm of infected cells 
(see Belsham and Bostock, 1988; Paul and Wimmer, 2015). This process requires the virus 
encoded RNA-dependent RNA polymerase (3D
pol
, see Figure 1). This enzyme catalyses the 
synthesis of a negative strand copy of the positive strand viral genome and then the nascent 
negative strand is used as the template for the production of new positive strand RNA 
molecules (reviewed in Paul and Wimmer, 2015).  Far more positive strand RNAs are made 
than negative strands. The positive strand RNAs can be packaged by the virus capsid proteins 
to make new virus particles. All the FMDV RNA is linked at its 5'-terminus to one of the 
different versions of the 3B peptide (3B1-3, also known as VPg, (King et al., 1980), see also 
Figure 1). The VPg acts as a protein primer for the synthesis of the viral RNA (Paul and 
Wimmer, 2015). The replication process is error prone, i.e. incorrect nt are incorporated into 
the RNA copies. Assessments of the error rate suggest that, on average, about 1 error is made 
for every 10,000 nt that are synthesized (Castro et al., 2005), i.e. nearly every genome has an 
error since almost 17,000 nt have to copied to make one new positive strand (by copying the 
negative strand). There is no known mechanism of proof reading activity in picornaviruses 
and thus the viral RNA represents a pool of closely related sequences; this pool is known as a 
quasi-species (see Domingo et al., 2012). It seems that there is a balance between the need to 
maintain a functional RNA sequence and the need to be able to adapt to new conditions. 
Modifications to the fidelity (that either increase or decrease the error rate) of the 3D
pol
 from 
picornaviruses reduce the “fitness” of the virus (see Korboukh et al., 2014). As a result of this 
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continuous generation of errors, the virus population is always evolving. The differences in 
sequence can modify the biology of the virus, (e.g. in its antigenicity or speed of replication) 
but can also be useful for identifying the sources of viruses that cause disease outbreaks.  
A more dramatic form of genome evolution, involving RNA recombination, can also occur 
between picornavirus genomes. During the process of RNA replication, it is possible for the 
RNA polymerase (3D
pol
) to switch from copying one positive strand template to another. This 
process can result in the formation of “chimeric” genomes, e.g. with the capsid coding 
sequences derived from one parental virus and some of the non-structural protein coding 
sequences derived from a different strain of virus (e.g. see Jamal et al., 2011b; Jackson et al., 
2007). Clearly, it requires that an animal is co-infected with distinctly different strains of the 
virus to enable this process to be detected.  
 
2.1 Analysis of FMDV sequence evolution in the field 
There have been significant advances in the understanding of FMD epidemiology during the 
last three decades largely due to the application of molecular techniques including reverse-
transcription polymerase chain reaction (RT-PCR) and nucleotide (nt) sequencing (. These 
methods have become the preferred techniques for the genetic differentiation and 
characterization of FMDV strains. This methodology was first used for the study of the 
epidemiology of FMD by Beck and Strohmaier (1987), who investigated the origin of 
serotype O and A FMDV outbreaks in Europe over a 20 year period using the sequence (ca. 
650nt) encoding the VP1 capsid protein (Figure 1). Soon afterwards, phylogenetic analysis of 
nucleotide coding sequences for the VP1 of FMDVs from serotypes O, A and C was 
published (Dopazo et al., 1988). Together, these studies provided an early insight into the 
genetic relationships between different FMDVs and highlighted certain regions within the 
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VP1 coding region that were diverse between strains while other regions were highly 
conserved. Since then, many studies have published nucleotide sequence analysis for all the 
seven serotypes of FMDV (e.g., Ayelet et al., 2009; Cottam et al., 2008a, b; Jamal et al., 
2011a, b, c; Valarcher et al., 2009; Sangula et al., 2011; Valdazo-González et al., 2012a; 
Dhikusooka et al., 2015). Over time, as sequencing technologies have improved, it has 
become easier to generate such data and it has become increasingly common to analyze 
(near) complete (ca. 8400 nt) genome sequences (e.g. Carrillo et al. 2005, Cottam et al., 
2008b; Jamal et al., 2011b; Valdazo-González et al., 2012a).  
Different regions of the genome vary in their degree of conservation across the different 
serotypes of FMDV.  Within the 5'-untranslated region (5'-UTR), the average nt identity 
between all serotypes is over 80% while for the entire polyprotein coding region (ca. 7000 nt) 
the lowest level of sequence identity between two isolates was 73% (Carrillo et al., 2005). 
However, the VP1 coding region is substantially more variable and shows only about 50-70% 
nt identity between all serotypes (Knowles and Samuel, 2003) and the encoded protein has 
the lowest proportion (24%) of invariant amino acids among the different products derived 
from the polyprotein (Carrillo et al, 2005).  
Knowledge of the nt sequence encoding VP1 is sufficient to classify a virus into its serotype 
and indeed the serotypes have been further classified into separate genotypes based on up to 
15% difference in the VP1 coding sequences (Jamal et al., 2011c; Knowles and Samuel, 
2003). On this basis, serotype O FMDVs, for example, from around the world have been 
classified into eight genetically and geographically distinct genotypes, which are referred to 
as topotypes (Knowles et al., 2016a). Similarly, a total of 26 regional genotypes have been 
identified within three continental topotypes (ASIA, AFRICA and EURO-SA) for serotype A 
FMDVs (Mohapatra et al., 2011), whereas, serotype Asia-1 FMDVs all belong to a single 
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topotype, ASIA. The SAT 1, SAT 2 and SAT 3 viruses have been classified into 8 (I to VIII), 
14 (I to XIV) and 5 (I to V) topotypes, respectively (Knowles et al., 2016a).     
2.2 Value of (near) full-length FMDV genome sequence 
Following introduction of FMDV into an area, which is normally disease-free, then the 
highly contagious nature of the virus means that the virus will spread rapidly among the 
animals within an infected premises and it can also spread easily to adjacent farms. During 
this process, as indicated above, the virus evolves due to its error prone mechanism of 
replication. In general, in the field, the virus consensus sequence changes at about 0.5-1% of 
its genome /yr (see Cottam et al., 2006). Thus, this means about 40-80nt changes accumulate 
per year or about 1-2 nt changes per week. Typically, during an outbreak, the virus infects a 
herd, spreads within it and is then transmitted to another herd; this process will take at least 
several days (maybe 1-2 weeks) and thus the virus population infecting different farms along 
a transmission pathway can be expected to be different. Analysis of the accumulation of nt 
changes within the virus in samples from each infected farm can therefore be used to identify 
a transmission pathway. This approach was used, retrospectively, on samples stored from the 
2001 outbreak in the U.K. (Cottam et al., 2006). During the subsequent FMD outbreak in the 
U.K. in 2007, complete genome sequences were generated within 24-48 h of receipt and were 
then used to track virus transmission essentially in “real time”. This information encouraged 
the search, using sero-surveillance, for an undisclosed, infected, premises that linked between 
the 2 separate phases of the outbreak (Cottam et al., 2008a,b).  The viruses from the first and 
second phases of the outbreak differed by 9 nt whereas usually, as in the 2001 outbreak, farm 
to farm transmission was accompanied by only about 4 nt changes (Cottam et al., 2008a). The 
sero-surveillance indeed identified previously undetected infection in sheep that had been 
present on those premises for at least 2 weeks and appeared to represent the link between the 
2 phases of the outbreak. 
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When the latest outbreak of FMDV occurred in Europe, in Bulgaria in 2011, the identified 
cases within domestic livestock were sampled and sequence analysis of the viruses was 
performed. This outbreak also had two distinct phases but all the viruses collected had a 
single common ancestor. The viruses involved had VP1 coding sequences (ca. 640nt), that 
were almost identical to those from other viruses within the ANT-10 sub-lineage of O/ME-
SA/PanAsia-2 that were known to be circulating, at that time, in Turkey and Israel (Valdazo-
González et al., 2011). However, by generating near full-length genome sequences, (based on 
8170 nt), then 44-60 nt differences were identified between these sequences and the virus 
responsible for the first case in Bulgaria (Valdazo-González et al., 2012b). The precise origin 
of the virus introduced into Bulgaria was not apparent. However, it was possible to identify a 
transmission pathway within Bulgaria involving the two different phases of the outbreak. 
Apparent gaps in the transmission pathway again suggested that undisclosed outbreaks had 
occurred and this was subsequently confirmed by serological analysis. This outbreak of 
FMDV was unusual in that it was initially detected in wild boar and serological evidence for 
infection of these animals (and deer) in the near vicinity of infected domestic animals was 
obtained (Alexandrov et al., 2013). However, after the outbreaks in domestic animals were 
eliminated, then the disease was not maintained in the wildlife and no new infections of 
domestic animals occurred (see Dhollander et al., 2016).   
These studies clearly show that useful information is generated by obtaining (near) full-length 
genome sequences. However, this process is fairly labour intensive, requiring the production 
and sequencing (in separate reactions) of multiple (5-20) RT-PCR products. Furthermore, this 
system only generates a consensus sequence; it does not give much information about the 
heterogeneity present within the virus populations. The advent of next generation sequencing 
(NGS), using a variety of different protocols for obtaining the sequence, can greatly facilitate 
11 
the procedure for obtaining a consensus sequence and can also offer the capability of 
analyzing the diversity of the virus population at each position along the genome.   
2.3 Use of NGS for virus characterization 
A variety of different approaches can be used to generate the material for NGS. These 
approaches are, of course, applicable to many different viruses (e.g. influenza virus, hepatitis 
C virus, HIV etc.) and for a variety of different purposes. In some studies on FMDV (e.g. 
King et al., 2016; Kristensen et al., 2017; Wright et al., 2011), large amplicons (overlapping 
if more than 1) were generated by RT-PCR and then these products were used to generate 
consensus sequences. However, in addition, the fact that large numbers of sequence reads 
were generated (usually thousands of reads per nt) allowed the analysis of the heterogeneity 
within the viral sequences to be analyzed.  This can permit, for example, the adaptation of the 
virus to be followed, either within cell culture (Kristensen et al., 2017) or during the course of 
infection within a single animal (Wright et al., 2011) or during the course of an outbreak 
(King et al., 2016). Variants, that initially only represent a few percent of the virus 
population, can rapidly increase during growth, in cell culture or in animals, and thus become 
dominant. This does illustrate the importance of analyzing samples without amplification in 
cell culture, if possible. New methods to improve the sensitivity of detection of such variants 
using NGS have been developed (e.g. circular sequencing, CirSeq, see review by Whitfield 
and Andino, 2016). No doubt, such analyses will increase the understanding of the virus 
quasi-species present within individual infected animals. Since there can be easily be over 
10
12
 separate FMDV genomes circulating at any one time within the blood of a single,
acutely infected bovine (Alexandersen et al., 2003), then even minor variants can still be 
present in large numbers. 
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Recently, a protocol, using NGS, has been described for the generation of consensus level 
FMDV genome sequences without the need for the production of large amplicons by RT-
PCR (Logan et al., 2014). This system has been shown to work on all seven serotypes of the 
virus and with material from clinical samples (epithelium suspension) and from cell culture 
grown virus. It seems likely that this type of approach will become increasingly common. 
However, it should be noted that the short reads generated by NGS may impose some 
limitations on the ability to identify recombination between different FMDV strains, if 
samples could contain the parental strains as well as recombinant strains.  
3.1 Spread of important FMDV strains 
As described earlier, phylogenetically related virus subtypes/strains within each serotype of 
FMDV are usually restricted to distinct geographical regions. However, there are known 
exceptions and occasional spread of subtypes/strains beyond their usually defined region 
occurs. Well known examples include the spread of viruses belonging to the O-PanAsia 
lineage (a member of the Middle East South Asia (ME-SA) topotype) from South Asia to the 
whole of the Asian continent. This virus lineage caused outbreaks in previously disease-free 
countries like Japan and South Korea and also spread to South Africa and the European 
Union (Knowles et al., 2005). Some other examples of recent, important, spread of strains 
from outside their usual geographical region are described below.    
3.1.1 O/Ind-2001 lineage 
The O/Ind-2001 lineage was initially reported in India in 2001 as a group of FMDVs distinct 
from the then predominant O-PanAsia lineage (Hemadri et al., 2002). The virus lineage 
termed O/Ind-2001 was, in fact, present in the Middle East as early as 1997 since it was 
detected, by the World Reference Laboratory for FMD (WRL-FMD), in samples that 
originated from Kuwait, Bahrain and the United Arab Emirates collected in 1997 (Knowles et 
13 
al., 2005). Sequencing of archived samples also revealed its existence in India as early as 
1997 (Subramaniam et al., 2015). Continued circulation of this lineage was initially restricted 
to northern states of India, causing sporadic cases of FMD prior to 2008 and it was largely 
eclipsed by the PanAsia lineage during the period 2003-2007 but re-emerged in 2008 
(Subramaniam et al., 2015).  However, since 2009, the O/Ind-2001 lineage showed 
predominance throughout the country (Subramaniam et al., 2013) outcompeting the 
previously dominant PanAsia lineage (Das et al, 2012). Viruses belonging to the O/Ind-2001 
lineage are native to India, Nepal, Bhutan and Bangladesh and these are classified as pool 2 
viruses. Sporadic incursions of these viruses have also been recorded in Kuwait (1997), the 
United Arab Emirates (1997, 2001, 2008-2009), Bahrain (1997, 2001), Israel (2002), Saudi 
Arabia, Oman (2001), Palestinian Autonomous Territories (2002) and Iran (2009) but with no 
further known spread of this lineage outside its geographical region until 2013. Since its 
initial identification in 1997 (from Kuwait), this lineage has diverged over time into four 
distinct sub-lineages, designated as Ind-2001a, Ind-2001b, Ind-2001c and Ind-2001d. The 
Ind-2001a sub-lineage largely includes the FMDVs responsible for outbreaks during 2001-
2002 in India (Subramaniam et al, 2013) and in the Middle East in 1997. The Ind-2001b sub-
lineage emerged in the year 2001, whereas the Ind-2001c and Ind-2001d sub-lineages 
emerged in 2008 and 2009, respectively. All the outbreaks involving the O/Ind2001 lineage 
that have occurred since 2013, outside of the Indian sub-continent, were caused by the O/Ind-
2001d sub-lineage (Figure 2). During 2013-14, the O/Ind-2001d sub-lineage was detected in 
gazelles in the United Arab Emirates and in samples from dairy farms in Saudi Arabia 
(WRL-FMD, 2014). Viruses belonging to this sub-lineage also reached North Africa in 2013 
and were then detected, for the first time, in Libya (in 2013), Tunisia (in 2014), Algeria (in 
2014) and Morocco (in 2015). These countries had been free of FMD for the previous 15 
years before these incursions and this lineage is now endemic in some of these countries 
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(Bachanek-Bankowska et al., 2016; Knowles et al., 2016b; Valdazo-Gonzalez et al., 2014). 
Phylogenetic analysis of viruses responsible for the outbreaks in Saudi Arabia (during August 
to November, 2013) and Libya (during September to November, 2013) revealed that these 
viruses showed close similarity to the viruses from India and Bhutan that were collected 
during 2013. In addition, these studies provided evidence that the FMD outbreaks in Saudi 
Arabia and Libya arose through separate introductions of this virus strain into these countries 
(Knowles et al., 2016b). Furthermore, phylogenetic analysis of FMDVs circulating in Saudi 
Arabia during 2013-2016 showed two different “branches” of viruses belonging to the O/Ind-
2001d sub-lineage. Viruses responsible for outbreaks during 2013-2014 clustered together, 
whereas viruses collected during 2015-2016 formed a distinct cluster (WRL-FMD, 2016a). 
This branching pattern showed that two different incursions of FMDVs occurred into Saudi 
Arabia during 2013-2016. This strain was also detected in Jordan in February, 2017 (WRL-
FMD, 2017a). The O/Ind-2001d sub-lineage also spread to two islands in the Republic of 
Mauritius in the Indian Ocean in July 2016 (WRL-FMD, 2016b), a country which was 
previously free of FMD without vaccination. Surprisingly, there is no evidence for spread of 
the O/Ind-2001d sub-lineage into Egypt and Pakistan. Apart from this westward movement of 
the virus, the O/Ind-2001d strain also spread towards the east and was first detected in South 
East Asia (Laos, Myanmar and Vietnam) in 2015 (Arzt et al., 2017; Qiu et al., 2017; Vu et 
al., 2017). It spread to Thailand in September 2016 causing outbreaks in cattle, buffalo and 
pigs (WRL-FMD, 2016b; OIE, 2017b). The O/Ind-2001d viruses collected from Laos and 
Vietnam were closely related to each other and showed high similarity to viruses that had 
previously circulated in India in 2013. However, viruses from Myanmar and Thailand 
showed divergence from the viruses of the same sub-lineage recovered from Laos and 
Vietnam but were closely related to viruses circulating in Bangladesh in 2015 (OIE, 2017b; 
Qiu et al., 2017), indicating that two different incursions of this sub-lineage have occurred in 
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South East Asia. The spread of this sub-lineage continues since it was also responsible for 
outbreaks in Mongolia in March 2015 (Nishi et al., 2017), in the eastern part of Russia in 
October 2016 and 2017 and in Western China (EuFMD, 2017). The O/Ind-2001d sub-lineage 
reached South Korea in February 2017 where it caused outbreaks in two separate regions 
(EuFMD, 2017; Ryoo et al., 2017). The VP1 coding sequences of FMDVs responsible for 
outbreaks in BoEun region showed closest identity (99.5%) with the virus responsible for 
FMD outbreak in Russia in 2016 (Zabaikalskiv/3/RUS/2016), whereas, that responsible for 
the outbreak in JeongEup city showed closest identity (99.7%) to an isolate from Bangladesh 
in 2015 (O/BAN/GO/ka-236) (Ryoo et al., 2017). The route of introduction of the O/Ind-
2001d sub-lineage into Russia and South Korea is difficult to ascertain, at present, due to the 
small extent of difference in sequences between these viruses and the non-availability of 
sequence data in public databases (at the time of writing). A map indicating the trans-regional 
spread of viruses belonging to the O/Ind-2001d sub-lineage is shown in Figure 3.  
 
3.1.2 O-PanAsia
ANT-10
 sub-lineage 
Serotype O FMDV belonging to a new sub-lineage within the O-PanAsia-II lineage was 
detected, for the first time, in a sample (O/TUR/12/2010) collected on June 19, 2010 from the 
East Anatolian region of Turkey. It was designated as the O-PanAsia-II
ANT-10
 sub-lineage by 
the WRL-FMD, after the name of the region in Turkey from where it originated. Virus 
belonging to this sub-lineage was also subsequently detected in a sample (IRN/88/2009; 
accession No. KY091282) collected on December 21, 2009 from Esfahan, Iran. Retrospective 
analysis of samples (O/KHI/PAK/08/2009; accession No. JX170745) collected on May 28, 
2009 from Karachi, Pakistan also detected this new sub-lineage, suggesting that the O-
PanAsia-II
 ANT-10
 sub-lineage may have originated from Pakistan (Brito et al., 2013). These 
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viruses have become one of the most widely distributed sub-lineages observed in the whole 
West Eurasian Region. Outbreaks of FMD due to this sub-lineage were also reported in South 
Ossetia (a region of Georgia) in 2011 (WRL-FMD, 2011a). This sub-lineage reached Africa 
and was detected in a sample collected on December 22, 2010 from Tripoli, Libya (WRL-
FMD, 2011b). This sub-lineage has, however, not been detected in Egypt (see WRL-FMD 
website: www.wrlfmd.org for update).  
As mentioned above, the O-PanAsia-II
 ANT-10
 sub-lineage was introduced into Europe and 
was detected in Bulgaria in a sample collected from wild boar on December 30, 2010 close to 
the border with Turkish Thrace, resulting in suspension of the FMD-free status of the 
country, which was previously disease-free since 1996. This outbreak was unusual in that it 
was first identified in wild boar and was only subsequently recognized within cattle, sheep, 
goats and swine in 12 outbreaks that lasted from the end of December 2010 until April, 2011. 
The epidemic was controlled by stamping out, quarantine and movement control. Bulgaria 
regained its FMD-free status in August 2012 (OIE, 2012). This was the most recent outbreak 
of FMD in Europe. A phylogenetic tree showing viruses belonging to the O-PanAsia-II
ANT-10
 
sub-lineage from different countries is shown in Figure 4 while Figure 5 shows the 
geographical spread of these viruses. 
 
3.1.3 O-EA-3 topotype 
Recently, outbreaks due to another serotype O FMDV were reported in the Palestinian 
Autonomous Territories and Israel in February, 2017. Sequencing revealed that these viruses 
belonged to the O/EA-3 topotype (WRL-FMD, 2017a), which is a component of the pool 4 
viruses, normally restricted to Eastern Africa. These viruses are very closely related to the 
viruses currently circulating in Egypt (in 2017) and Ethiopia (in 2017) and are somewhat 
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related to FMDVs circulating in Sudan in 2013 and in Egypt in 2015-16 (see WRL-FMD, 
2017b, c, d). 
 
3.1.4 A-Iran05 lineage 
The A-Iran05 lineage of FMDV was first identified in samples from Iran collected in 2003 
(Knowles et al., 2009) and was then reported in samples from Afghanistan in 2004 (Klein et 
al., 2007; Schumann et al., 2008). This sub-lineage subsequently spread to Turkey and Saudi 
Arabia in 2005 and spread further in the Middle East, superseding other lineages like A-
IRN96 and A-IRN99 that were previously dominant in the region (Klein et al., 2006).  This 
lineage was also detected in Pakistan and Jordan in 2006 and was responsible for extensive 
disease outbreaks in early 2006 within the Thrace region of Turkey. Viruses belonging to this 
lineage have evolved to form different sub-lineages including A-Iran05
AFG-07
, A-Iran05
BAR-08
, 
A-Iran05
BAD-09
, A-Iran05
KUN-09
, A-Iran05
FAR-09
, A-Iran05
HER-10
, A-Iran05
FAR-11
, A-Iran05
BAL-
11
, etc. (Jamal et al., 2011c; Ullah et al., 2017) (see Figure 6). Viruses belonging to the A-
Iran05
BAR-08
 were initially detected by WRL-FMD in samples from Bahrain collected from 
animals suspected of having FMD on November 24, 2008 (Knowles et al., 2009). However, it 
should be noted that Jamal et al. (2011c) reported the presence of this sub-lineage in an oral 
swab sample collected on July 23, 2008 from an apparently healthy animal in a live animal 
market in Kabul, Afghanistan. In early 2009, this sub-lineage reached Africa and was 
detected in Libya (WRL-FMD) and then during October 2010 in Egypt (WRL-FMD, 2012). 
The geographical spread of FMDVs belonging to the A-Iran05
BAR-08
 sub-lineage is shown in 
Figure 7. Surprisingly, no eastward spread of the A-Iran05 lineage has been reported. There 
is a poor antigenic match between the A/22/Iraq vaccine and viruses belonging to the A-
Iran05
BAR-08
 sub-lineage (WRL-FMD 2009, 2010a, b, c). Mapping of the amino acid changes 
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between the structural proteins of A22/Iraq and the A-Iran05
BAR-08
 viruses onto the A22/Iraq 
capsid structure revealed candidate amino acid substitutions exposed on the virus structure, 
which may explain this antigenic difference (Jamal et al., 2011c).   
 
3.1.5 A/Asia/G-VII 
Serotype A viruses belonging to the G-VII genotype were initially detected in the Indian State 
of Assam in 1989 from where they rapidly spread to other Indian states (Tosh et al., 2002). 
This genotype belongs to the pool 2 of FMD viruses and is thus native to the Indian sub-
continent, excluding Pakistan. Viruses belonging to this genotype were also responsible for 
FMD outbreaks in Saudi Arabia in 1995-1996. This genotype also resulted in a large 
epidemic of FMD in Albania in 1996, due to importation of infected buffalo meat “on the 
bone” from India (Kitching, 1998; Valarcher et al., 2008). The disease spread further to 
Macedonia, from the neighbouring Albania, in the same year.  Since then, viruses belonging 
to this genotype have not been reported outside their usual geographical region until 2015 
when they were detected in Iran, Saudi Arabia, Turkey and Armenia (WRL-FMD, 2015). 
Outbreaks of disease due to serotype A FMDV had not been reported in Saudi Arabia since 
2005, when outbreaks due to a virus belonging to the A-Iran05 lineage had occurred. During 
2015, this G-VII genotype strain was detected for the first time in Armenia and Iran and again 
in Saudi Arabia in 2016 (WRL-FMD, 2015, 2016). A phylogenetic tree showing viruses 
belonging to the A/G-VII genotype is shown in Figure 8. In vitro and in vivo studies indicate 
that vaccine based on the A-Iran05 strain, which is currently in use in the West Eurasian 
region, is unlikely to provide efficient protection against this genotype. The A/G-VII 
genotype was detected in Israel in early 2017 (WRL-FMD, 2017b). New waves of infection 
due to this genotype have also occurred in Turkey during 2016 and the disease has spread to 
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the margins of Anatolian Turkey, close to the FMD-free zone in the Thrace region (WRL-
FMD, 2016b), which poses a concern for spread of this genotype into Europe.  A map 
showing the spread of A/G-VII viruses is shown in Figure 9. 
3.1.6 A/Africa/G-IV 
New FMD outbreaks have recently been detected in Algeria and Tunisia due to serotype A 
FMDV. These are the first cases of FMD due to serotype A in any Maghreb country in more 
than 30 years (King et al., 2017). These viruses have been characterized as belonging to the 
A/Africa/G-IV genotype and phylogenetic analysis showed a West African origin (WRL-
FMD, 2017a, b). Other recent field outbreaks due to this strain have been reported in Egypt 
(in 2015-16), Nigeria (in 2015), Cameroon (in 2013) and Ethiopia (in 2015) (WRL-FMD, 
2017a, b, d).      
3.1.7 Group-VII (Sindh-08) of serotype Asia-1 virus 
A new genetic group within the serotype Asia-1 FMDVs emerged in recent years. Viruses 
belonging to this new genetic group within this serotype were first reported from Southern 
Pakistan in late 2008 and then in early 2009 and were named as Group-VII (Jamal et al., 
2011b). The WRL-FMD designated this strain as Sindh-08 (Knowles et al., 2016a). This virus 
subsequently spread to other parts of the country and it was then detected in Iran in January 
2011 and also in Afghanistan and Bahrain. This strain moved further eastwards and was 
detected in Turkey in June 2011.  It was also reported in Tajikistan in the same year (WRL-
FMD, 2012) and is currently dominant throughout the West Eurasian regions and has 
completely replaced the Group-II and Group-VI viruses that were previously circulating in 
the region (Brito et al., 2017). FMD outbreaks due to this strain have not yet been reported 
outside its original geographical region. However, it has caused significant problems since the 
Asia-1/Shamir vaccine, which is frequently used to combat serotype Asia-1, does not provide 
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sufficient protection against this virus (Knight-Jones et al., 2014). Indeed, viruses belonging 
to this genetic group are not efficiently neutralized by antisera raised against the Asia-
1/Shamir and Asia-1/Ind/8/79 vaccine strains (Jamal et al., 2011b). Fortunately, a 
homologous vaccine prepared using an isolate from this genetic group (Asia-1/TUR/11) that 
was responsible for an outbreak in Turkey in 2011, has been found to be effective for 
containing the spread of these Sindh-08 (Group-VII) viruses (Knight-Jones et al., 2014). A 
phylogenetic tree showing FMDVs belonging to the Sind-08 (Group-VII) is shown in Figure 
10. 
3.1.8 SAT 2 topotypes VII and IV 
Widespread FMD outbreaks due to the SAT 2 serotype were reported in Egypt and Libya 
during February and March 2012 (Ahmed et al., 2012; FAO, 2012). These were the first 
outbreaks due to this serotype of FMDV in Egypt since 1950 and the first re-introduction of 
this serotype into Libya since 2003. The SAT 2 FMDVs responsible for outbreaks in Egypt in 
2012 belonged to topotype VII of serotype SAT 2 FMDV. Viruses belonging to this topotype 
have previously been reported in Eritrea, Uganda, Cameroon, Nigeria and Sudan (Ahmed et 
al., 2012). The SAT 2 viruses responsible for the 2012 outbreaks in Egypt belonged to two 
different lineages within topotype VII i.e. Ghb-12 and Alx-12. The lineage SAT 2/VII/Ghb-
12 was responsible for outbreaks in Gharbia, Faiyum, Giza, Kafr el-Sheikh, Minya, Monufia, 
Qalyubia and Suiz Governorates, whereas, the SAT 2/VII/Alex-12 lineage was found in the 
Alexandria Governorate in Egypt (Ahmed et al., 2012). During April and May 2012, 
additional outbreaks due to SAT 2/VII/Ghb-12 lineage occurred in Egypt (WRL-FMD, 
2012). The presence of two different lineages indicated two independent introductions of 
SAT 2 FMDVs in Egypt in 2012. The SAT 2 FMDVs responsible for outbreaks in Libya 
belonged to the Lib-12 lineage, which were not only distinct from the SAT 2 lineages in 
Egypt in 2012 but were also distinct from previous SAT 2 FMDVs responsible for outbreaks 
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in 2003 in Libya (Ahmed et al., 2012). These finding suggest independent incursions of SAT 
2 FMDVs into Libya and Egypt.    
Outbreaks of disease due to SAT 2 FMDVs were reported in the Palestinian Autonomous 
Territories and in Bahrain in April, 2012. The SAT 2 virus from the Palestinian Autonomous 
Territories belonged to the SAT2/VII/Ghb-12 lineage and was most closely related to viruses 
from Egypt in 2012, showing 99.5% nucleotide identity in the whole genome (Valdozo-
Gonzalez et al., 2012a). The SAT 2 virus from Bahrain, however, belonged to the Ken-09 
lineage within the topotype IV and was closely related to viruses occurring in Kenya in 2009. 
This was the first known detection of SAT 2 serotype in Bahrain (WRL-FMD, 2012). In 
April 2015, SAT 2/VII/Alex-12 lineage virus was detected in Oman which showed high 
similarity to the viruses circulating in Ethiopia in 2014-2015 (WRL-FMD, 2015).  
4.1.1 Concluding remarks 
FMDV remains an important threat to intensive animal production. The virus continuously 
evolves and sometimes new strains arise that display features which make them difficult to 
control, e.g. as with the serotype Asia-1 virus within Group-VII (Sindh-08) that is able to 
infect animals vaccinated with the commonly used vaccine strains (e.g. Asia-1/Shamir). 
However, it is interesting to note that some long established vaccine strains still have the 
ability to contain spread of the disease caused by “new” virus strains (see Mahapatra et al., 
2017). Trans-pool movements of virus strain(s) can further complicate the epidemiological 
situation and disease control due to antigenic mismatch between the invader virus strain and 
the vaccine strain(s) already in use in the region. The emergence of O/Ind-2001d and 
A/Africa/G-IV viruses in the neighbourhood of Europe pose threats to these FMD-free 
countries. Such events highlight the ease with which FMD can cross international boundaries 
and emphasize the importance of continuous molecular epidemiological studies on the 
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circulating viruses. The development of rapid, (near) full-length genome sequencing is a 
powerful tool for determining routes of virus transmission. Apparent gaps in such 
transmission chains have encouraged the search for unrecognized sites of infection and the 
discovery of such premises improves disease control. The knowledge of the virus genome 
sequences can also assist in the identification of specific changes in the virus capsid 
responsible for antigenic change.  
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Figure legends 
Figure 1. Genome organization of FMDV. The RNA genome encodes a polyprotein that is 
processed, largely by virus-encoded proteases into 15 mature products. The virus capsid 
comprises 60 copies of VP1, VP2, VP3 and VP4 while the non-structural proteins are mainly 
involved in virus replication (e.g. 3D
pol
).   
Figure 2. Neighbour-Joining phylogenetic tree showing different sub-lineages within the 
FMDV O/ME-SA/Ind-2001 lineage. The tree was constructed using MEGA 7 using selected 
nucleotide sequences (nt=639) encoding the capsid protein VP1 that are available in public 
databases. The sequences were included to show different sub-lineages within the O/Ind-2001 
lineage plus some reference sequences (e.g., O/UKG/35/2001 and O1/Manisa/Turkey/69). 
Figure 3. Trans-regional spread of FMD viruses belonging to the O/Ind-2001d sub-
lineage. The O/Ind-2001d sub-lineage is native to countries marked in red. Countries where 
outbreak(s) due to the O/Ind-2001d sub-lineage have been recorded are shown in blue except 
for Russia where the region of the outbreak is shown in yellow. Arrows indicate the trans-
regional spread and the year indicates the first recorded introduction into the respective 
countries. Dotted arrows indicate unknown routes of introduction.  
Figure 4. Neighbouring-Joining phylogenetic tree including FMDVs belonging to the O-
PanAsia-II
ANT-10
 sub-lineage. The tree was constructed using MEGA 7 using selected 
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nucleotide sequences (nt=639) encoding the capsid protein VP1  that are available in public 
databases. The sequences were included to show viruses belonging to the O-PanAsia-II
ANT-10
sub-lineages with some representative viruses belonging to the O-PanAsia lineage and a 
group of viruses belonging to the O/Ind-2001 lineage. 
Figure 5. Trans-regional spread of viruses belonging to the O-PanAsia-II
ANT-10
 sub-
lineage. The O-PanAsia-II
ANT-10
 sub-lineage is native to countries marked in red. Countries
where trans-regional outrbreak(s) due to the O-PanAsia-II
ANT-10
 sub-lineage have been
recorded are shown in blue. The year of first recorded introduction of the virus is shown on 
the countries. 
Figure 6. Neighbour-Joining phylogenetic tree showing the different sub-lineages within 
the A-Iran05 lineage. The tree was constructed using MEGA 7 using selected nucleotide 
sequences (nt=639) encoding the capsid protein VP1  that are available in public databases. 
The sequences included are from different sub-lineages within the A-Iran05 lineage plus 
some representative sequences belonging to the A-IRN99, A-IRN-96 and A-IRN-87 lineages 
and a reference sequence (A22/Iraq/64).  
Figure 7. Trans-regional spread of viruses belonging to the A-Iran05
BAR-08
 sub-lineage. 
The A-Iran05
BAR-08 
sub-lineage is native to countries marked in red. Countries where trans-
regional outrbreak(s) due to the A-Iran05
BAR-08
 sub-lineage have been recorded are shown in
blue. The year of first recorded introduction of the virus is shown on the countries.  
Figure 8. Neighbour-Joining phylogenetic tree showing FMDVs belonging to the A/G-
VII genotype. The tree was constructed using MEGA 7 using selected nucleotide sequences 
(nt=639) encoding the capsid protein VP1  that are available in public databases. The tree 
also shows viruses belonging to the A-Iran05, A-IRN99 and A-IRN87 lineages and a 
reference sequence (A22/Iraq/64).  
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Figure 9. Trans-regional spread of viruses belonging to the A/Asia/G-VII genotype. The 
A/Asia/G-VII genotype is native to countries marked in red. Countries where outbreak(s) due 
to the A/Asia/G-VII genotype have been recorded are shown in blue. Arrows indicate the 
trans-regional spread and the year of first recorded introduction of the virus is indicated. 
Figure 10. Phylogenetic tree showing FMDVs belonging to the Sindh08 (Group-VII) 
within the Asia-1 serotype. The tree was constructed using MEGA 7 using selected 
nucleotide sequences (nt=633) encoding the capsid protein VP1 that are available in public 
databases. Other strains/groups of serotype Asia-1 FMDVs circulating in West Eurasian 
region also also shown.  
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